2022 Q1 Form 10-Q Financial Statement

#000008908922000036 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q3 2021 Q1
Revenue $1.112B $1.034B $1.078B
YoY Change 3.19% 12.65% 34.25%
Cost Of Revenue $735.5M $701.4M $695.5M
YoY Change 5.74% 7.14% 11.48%
Gross Profit $376.9M $333.0M $382.4M
YoY Change -1.45% 26.31% 113.6%
Gross Profit Margin 33.88% 32.2% 35.48%
Selling, General & Admin $41.70M $36.48M $36.70M
YoY Change 13.63% -11.03% 15.41%
% of Gross Profit 11.06% 10.95% 9.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $42.44M $67.65M $39.56M
YoY Change 7.28% -3.08% 4.34%
% of Gross Profit 11.26% 20.31% 10.34%
Operating Expenses $41.70M $36.48M $36.70M
YoY Change 13.63% -11.03% 15.41%
Operating Profit $335.7M $304.3M $342.0M
YoY Change -1.85% 36.35% 125.36%
Interest Expense $39.03M $38.62M $35.81M
YoY Change 8.98% -5.16% -19.25%
% of Operating Profit 11.63% 12.69% 10.47%
Other Income/Expense, Net $128.0K $8.218M $341.0K
YoY Change -62.46% 1206.52% -127.35%
Pretax Income $296.8M $273.9M $306.6M
YoY Change -3.19% 66.19% 189.11%
Income Tax $77.23M $64.00M $77.61M
% Of Pretax Income 26.02% 23.36% 25.32%
Net Earnings $219.5M $209.9M $228.9M
YoY Change -4.09% 64.7% 179.32%
Net Earnings / Revenue 19.73% 20.29% 21.23%
Basic Earnings Per Share $1.36 $1.25 $1.35
Diluted Earnings Per Share $1.34 $1.23 $1.33
COMMON SHARES
Basic Shares Outstanding 161.3M shares 167.4M shares 169.9M shares
Diluted Shares Outstanding 163.8M shares 170.0M shares 172.4M shares

Balance Sheet

Concept 2022 Q1 2021 Q3 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $300.6M $406.9M $244.0M
YoY Change 23.18% 84.98% 38.64%
Cash & Equivalents $300.6M $406.9M $243.7M
Short-Term Investments
Other Short-Term Assets $26.49M $40.27M $28.22M
YoY Change -6.15% 0.83% -64.83%
Inventory $28.65M $24.65M $25.95M
Prepaid Expenses
Receivables $63.94M $100.0M $90.00M
Other Receivables $39.10M $0.00 $0.00
Total Short-Term Assets $458.7M $571.9M $387.5M
YoY Change 18.39% 56.22% 7.79%
LONG-TERM ASSETS
Property, Plant & Equipment $2.255B $2.161B $2.137B
YoY Change 5.53% 2.25% 3.84%
Goodwill $1.917B $1.884B $1.883B
YoY Change 1.83% 0.87% 1.13%
Intangibles
YoY Change
Long-Term Investments $7.765B $7.774B $7.431B
YoY Change 4.49% 19.5% 34.13%
Other Assets $1.171B $1.114B $1.085B
YoY Change 7.9% 5.97% 6.74%
Total Long-Term Assets $15.00B $14.80B $14.40B
YoY Change 4.15% 10.26% 16.55%
TOTAL ASSETS
Total Short-Term Assets $458.7M $571.9M $387.5M
Total Long-Term Assets $15.00B $14.80B $14.40B
Total Assets $15.46B $15.37B $14.79B
YoY Change 4.52% 11.48% 16.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $645.1M $623.3M $550.0M
YoY Change 17.3% 18.73% 15.79%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $63.86M $65.81M $217.1M
YoY Change -70.58% -31.35% 152.74%
Total Short-Term Liabilities $775.2M $724.3M $841.8M
YoY Change -7.91% 16.42% 43.33%
LONG-TERM LIABILITIES
Long-Term Debt $3.963B $3.760B $3.439B
YoY Change 15.23% 4.9% -2.73%
Other Long-Term Liabilities $427.2M $444.5M $423.1M
YoY Change 0.99% 9.19% 20.66%
Total Long-Term Liabilities $4.390B $4.204B $3.862B
YoY Change 13.67% 5.33% -0.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $775.2M $724.3M $841.8M
Total Long-Term Liabilities $4.390B $4.204B $3.862B
Total Liabilities $5.165B $4.929B $4.704B
YoY Change 9.81% 6.83% 5.15%
SHAREHOLDERS EQUITY
Retained Earnings $678.9M $746.0M $662.3M
YoY Change 2.52% 34.06% 17.73%
Common Stock $957.2M $989.8M $975.2M
YoY Change -1.85% -0.23% -3.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.843B $1.942B $1.851B
YoY Change
Total Liabilities & Shareholders Equity $15.46B $15.37B $14.79B
YoY Change 4.52% 11.48% 16.3%

Cashflow Statement

Concept 2022 Q1 2021 Q3 2021 Q1
OPERATING ACTIVITIES
Net Income $219.5M $209.9M $228.9M
YoY Change -4.09% 64.7% 179.32%
Depreciation, Depletion And Amortization $42.44M $67.65M $39.56M
YoY Change 7.28% -3.08% 4.34%
Cash From Operating Activities $332.2M $240.6M $297.6M
YoY Change 11.62% 23.32% 65.34%
INVESTING ACTIVITIES
Capital Expenditures -$56.75M -$74.61M -$42.30M
YoY Change 34.16% 46.86% -19.12%
Acquisitions $0.00 $1.200M
YoY Change -100.0% -95.44%
Other Investing Activities $1.094M $2.464M -$2.700M
YoY Change -140.52% -110.9% -84.48%
Cash From Investing Activities -$55.65M -$72.14M -$45.02M
YoY Change 23.63% -1.58% -35.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $256.4M $106.1M
YoY Change 141.54% -13.78%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$251.7M -192.1M -$243.0M
YoY Change 3.57% 26.83% 120.77%
NET CHANGE
Cash From Operating Activities $332.2M 240.6M $297.6M
Cash From Investing Activities -$55.65M -72.14M -$45.02M
Cash From Financing Activities -$251.7M -192.1M -$243.0M
Net Change In Cash $27.38M -23.69M $10.98M
YoY Change 149.45% -20.23% -237.1%
FREE CASH FLOW
Cash From Operating Activities $332.2M $240.6M $297.6M
Capital Expenditures -$56.75M -$74.61M -$42.30M
Free Cash Flow $388.9M $315.2M $339.9M
YoY Change 14.42% 28.18% 46.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
159164117 shares
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000089089
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-6402-1
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
SERVICE CORPORATION INTERNATIONAL
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-1488375
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1929 Allen Parkway
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77019
CY2022Q1 dei City Area Code
CityAreaCode
(713)
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
522-5141
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock ($1 par value)
CY2022Q1 dei Trading Symbol
TradingSymbol
SCI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
CY2022Q1 us-gaap Revenues
Revenues
1112403000 USD
CY2021Q1 us-gaap Revenues
Revenues
1077981000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
735490000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
695538000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
376913000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
382443000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41704000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41669000 USD
CY2022Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-489000 USD
CY2021Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-1266000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
335698000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
342040000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
39028000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
35812000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
341000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
296798000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
306569000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77231000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77614000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
219567000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
228955000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
54000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
76000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
219513000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
228879000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161328000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169918000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163807000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172367000 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
219567000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
228955000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7279000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5005000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
226846000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
233960000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
54000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
76000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
226792000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
233884000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300556000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268626000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5849000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6338000 USD
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
103034000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
106051000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
28654000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
25935000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
26488000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40448000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
458732000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
441060000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
21283000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
20727000 USD
CY2022Q1 sci Preneedreceivablesnetandtrustinvestments
Preneedreceivablesnetandtrustinvestments
5870456000 USD
CY2021Q4 sci Preneedreceivablesnetandtrustinvestments
Preneedreceivablesnetandtrustinvestments
6015323000 USD
CY2022Q1 sci Cemetery Property At Cost
CemeteryPropertyAtCost
1890932000 USD
CY2021Q4 sci Cemetery Property At Cost
CemeteryPropertyAtCost
1900844000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2254916000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2252158000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1916965000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1915082000 USD
CY2022Q1 sci Allowance For Credit Losses For Deferred Charges And Other Assets
AllowanceForCreditLossesForDeferredChargesAndOtherAssets
3917000 USD
CY2021Q4 sci Allowance For Credit Losses For Deferred Charges And Other Assets
AllowanceForCreditLossesForDeferredChargesAndOtherAssets
4577000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1171065000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1169813000 USD
CY2022Q1 sci Cemetery Perpetual Care Trust Investments
CemeteryPerpetualCareTrustInvestments
1894068000 USD
CY2021Q4 sci Cemetery Perpetual Care Trust Investments
CemeteryPerpetualCareTrustInvestments
1996898000 USD
CY2022Q1 us-gaap Assets
Assets
15457134000 USD
CY2021Q4 us-gaap Assets
Assets
15691178000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
645125000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
659494000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
63863000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
65016000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
66217000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3751000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
775205000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
728261000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3824000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3962944000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3901304000 USD
CY2022Q1 sci Deferredpreneedrevenue
Deferredpreneedrevenue
1567217000 USD
CY2021Q4 sci Deferredpreneedrevenue
Deferredpreneedrevenue
1532749000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
436459000 USD
CY2021Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
437902000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
427234000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
438903000 USD
CY2022Q1 sci Deferred Preneed Funeral And Cemetery Receipts Held In Trust
DeferredPreneedFuneralAndCemeteryReceiptsHeldInTrust
4574762000 USD
CY2021Q4 sci Deferred Preneed Funeral And Cemetery Receipts Held In Trust
DeferredPreneedFuneralAndCemeteryReceiptsHeldInTrust
4766492000 USD
CY2022Q1 sci Care Trusts Corpus
CareTrustsCorpus
1870667000 USD
CY2021Q4 sci Care Trusts Corpus
CareTrustsCorpus
1976118000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
166975651 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
166821502 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159164117 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
163114202 shares
CY2022Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
159164000 USD
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
163114000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
957161000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
979096000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
678932000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
727021000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
47493000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40214000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1842750000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1909445000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
-104000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
4000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1842646000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1909449000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15457134000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15691178000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
219567000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
228955000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
42436000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
39558000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5074000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5335000 USD
CY2022Q1 sci Amortization Of Cemetery Property
AmortizationOfCemeteryProperty
24849000 USD
CY2021Q1 sci Amortization Of Cemetery Property
AmortizationOfCemeteryProperty
28929000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1644000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1526000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3078000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4580000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
553000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
489000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1266000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3687000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3500000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5435000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2525000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2714000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12204000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
52003000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
43046000 USD
CY2022Q1 sci Increase Decrease In Preneed Funeral Receivables Net And Trust Investments
IncreaseDecreaseInPreneedFuneralReceivablesNetAndTrustInvestments
91641000 USD
CY2021Q1 sci Increase Decrease In Preneed Funeral Receivables Net And Trust Investments
IncreaseDecreaseInPreneedFuneralReceivablesNetAndTrustInvestments
66194000 USD
CY2022Q1 sci Increase Decrease In Deferred Preneed Funeral Revenue
IncreaseDecreaseInDeferredPreneedFuneralRevenue
-67625000 USD
CY2021Q1 sci Increase Decrease In Deferred Preneed Funeral Revenue
IncreaseDecreaseInDeferredPreneedFuneralRevenue
-19660000 USD
CY2022Q1 sci Increase Decrease In Deferred Preneed Funeral Receipts Held In Trust
IncreaseDecreaseInDeferredPreneedFuneralReceiptsHeldInTrust
-6199000 USD
CY2021Q1 sci Increase Decrease In Deferred Preneed Funeral Receipts Held In Trust
IncreaseDecreaseInDeferredPreneedFuneralReceiptsHeldInTrust
141000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
332173000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
297606000 USD
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
56748000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
42274000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1160000 USD
CY2022Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
226000 USD
CY2021Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
5608000 USD
CY2022Q1 sci Proceeds From Divestitures And Sales Of Property And Equipment Net
ProceedsFromDivestituresAndSalesOfPropertyAndEquipmentNet
2986000 USD
CY2021Q1 sci Proceeds From Divestitures And Sales Of Property And Equipment Net
ProceedsFromDivestituresAndSalesOfPropertyAndEquipmentNet
4045000 USD
CY2022Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
1666000 USD
CY2021Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
18000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55654000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45015000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
75000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
20000000 USD
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
9075000 USD
CY2021Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
9023000 USD
CY2022Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
0 USD
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
100000000 USD
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9059000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6652000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
272000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2282000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
256355000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
106135000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39964000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
35568000 USD
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12517000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7932000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-251698000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-243028000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2556000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1412000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27377000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10975000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278555000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238610000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
305932000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249585000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1752621000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
233960000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
210
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
35568000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3500000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2364000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
106217000 USD
CY2021Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1850660000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1909449000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
226846000 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
250
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
39964000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3687000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
272000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
256355000 USD
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
162000 USD
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1127000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1842646000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
Nature of Operations
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#4b7282;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:130%">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. As a result, actual results could differ from these estimates.</span></div>
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300556000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268626000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3291000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7847000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2085000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2082000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5376000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9929000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
305932000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278555000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
108883000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5849000 USD
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
103034000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
112389000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6338000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
106051000 USD
CY2022Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1292600000 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1243781000 USD
CY2022Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
6243312000 USD
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
6536851000 USD
CY2022Q1 sci Insurancebackedfixedincomesecuritiesandother
Insurancebackedfixedincomesecuritiesandother
228612000 USD
CY2021Q4 sci Insurancebackedfixedincomesecuritiesandother
Insurancebackedfixedincomesecuritiesandother
231589000 USD
CY2022Q1 us-gaap Investments
Investments
6471924000 USD
CY2021Q4 us-gaap Investments
Investments
6768440000 USD
CY2022Q1 sci Cemetery Perpetual Care Trust Investments
CemeteryPerpetualCareTrustInvestments
1894068000 USD
CY2021Q4 sci Cemetery Perpetual Care Trust Investments
CemeteryPerpetualCareTrustInvestments
1996898000 USD
CY2022Q1 sci Preneedtrustinvestments
Preneedtrustinvestments
4577856000 USD
CY2021Q4 sci Preneedtrustinvestments
Preneedtrustinvestments
4771542000 USD
CY2022Q1 sci Preneedreceivablesnetandtrustinvestmentsexcludingallowanceforcancellation
Preneedreceivablesnetandtrustinvestmentsexcludingallowanceforcancellation
5870456000 USD
CY2021Q4 sci Preneedreceivablesnetandtrustinvestmentsexcludingallowanceforcancellation
Preneedreceivablesnetandtrustinvestmentsexcludingallowanceforcancellation
6015323000 USD
CY2022Q1 sci Preneed Accounts Receivable Gross
PreneedAccountsReceivableGross
1335300000 USD
CY2022Q1 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
21417000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1313883000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
21283000 USD
CY2022Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1292600000 USD
CY2021Q4 sci Preneed Accounts Receivable Gross
PreneedAccountsReceivableGross
1287722000 USD
CY2021Q4 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
23214000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1264508000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
20727000 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1243781000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated In Current Fiscal Year
AccountsReceivableNoncurrentOriginatedInCurrentFiscalYear
169734000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated In Fiscal Year Before Latest Fiscal Year
AccountsReceivableNoncurrentOriginatedInFiscalYearBeforeLatestFiscalYear
540003000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated Two Years Before Latest Fiscal Year
AccountsReceivableNoncurrentOriginatedTwoYearsBeforeLatestFiscalYear
310945000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated Three Years Before Latest Fiscal Year
AccountsReceivableNoncurrentOriginatedThreeYearsBeforeLatestFiscalYear
150023000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1027000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated Four Years Before Latest Fiscal Year
AccountsReceivableNoncurrentOriginatedFourYearsBeforeLatestFiscalYear
78010000 USD
CY2022Q1 us-gaap Accounts Receivable Noncurrent Originated Five Or More Years Before Latest Fiscal Year
AccountsReceivableNoncurrentOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
65168000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1313883000 USD
CY2022Q1 sci Total Preneed Receivables Past Due
TotalPreneedReceivablesPastDue
94156000 USD
CY2022Q1 sci Preneed Receivable Not Past Due
PreneedReceivableNotPastDue
1219727000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1313883000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
20727000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-1579000 USD
CY2022Q1 sci Effectof Foreign Exchangeon Allowancefor Credit Loss
EffectofForeignExchangeonAllowanceforCreditLoss
4000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
21283000 USD
CY2022Q1 sci Deposits To Trust
DepositsToTrust
127972000 USD
CY2021Q1 sci Deposits To Trust
DepositsToTrust
120283000 USD
CY2022Q1 sci Withdrawals From Trust
WithdrawalsFromTrust
122364000 USD
CY2021Q1 sci Withdrawals From Trust
WithdrawalsFromTrust
112580000 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
469312000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
431801000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
394424000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
427503000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
103555000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
130187000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
27932000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
16168000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Amortized Cost Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostBeforeAllowanceForCreditLoss
3966026000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
651813000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
233462000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
4384377000 USD
CY2022Q1 sci Available For Sale Securities Estimated Maturity Date Minimum
AvailableForSaleSecuritiesEstimatedMaturityDateMinimum
2022
CY2022Q1 sci Available For Sale Securities Estimated Maturity Date Maximum
AvailableForSaleSecuritiesEstimatedMaturityDateMaximum
2040
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
52873000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
24526000 USD
CY2021Q1 sci Net Preneed Deferred Sales
NetPreneedDeferredSales
313483000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4996000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
201000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
82596000 USD
CY2022Q1 sci Investment Earnings Net
InvestmentEarningsNet
45900000 USD
CY2021Q1 sci Investment Earnings Net
InvestmentEarningsNet
45000000 USD
CY2022Q1 sci Ecf Investment Earnings Net
ECFInvestmentEarningsNet
24400000 USD
CY2021Q1 sci Ecf Investment Earnings Net
ECFInvestmentEarningsNet
20800000 USD
CY2022Q1 sci Deferredrevenue Gross
DeferredrevenueGross
2330418000 USD
CY2021Q4 sci Deferredrevenue Gross
DeferredrevenueGross
2259364000 USD
CY2022Q1 sci Amounts Duefor Unfulfilled Performance Obligations
AmountsDueforUnfulfilledPerformanceObligations
763201000 USD
CY2021Q4 sci Amounts Duefor Unfulfilled Performance Obligations
AmountsDueforUnfulfilledPerformanceObligations
726615000 USD
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
1567217000 USD
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1532749000 USD
CY2021Q4 sci Deferredrevenueanddeferredreceiptsheldintrust
Deferredrevenueanddeferredreceiptsheldintrust
6299240000 USD
CY2020Q4 sci Deferredrevenueanddeferredreceiptsheldintrust
Deferredrevenueanddeferredreceiptsheldintrust
5761291000 USD
CY2022Q1 sci Net Preneed Deferred Sales
NetPreneedDeferredSales
391243000 USD
CY2022Q1 sci Deferred Revenue Acquisitions Dispositions Of Businesses Net
DeferredRevenueAcquisitionsDispositionsOfBusinessesNet
269000 USD
CY2021Q1 sci Deferred Revenue Acquisitions Dispositions Of Businesses Net
DeferredRevenueAcquisitionsDispositionsOfBusinessesNet
-441000 USD
CY2022Q1 sci Deferred Investment Earnings Net
DeferredInvestmentEarningsNet
-201580000 USD
CY2021Q1 sci Deferred Investment Earnings Net
DeferredInvestmentEarningsNet
146160000 USD
CY2022Q1 sci Recognized Revenue From Backlog
RecognizedRevenueFromBacklog
-176913000 USD
CY2021Q1 sci Recognized Revenue From Backlog
RecognizedRevenueFromBacklog
-156461000 USD
CY2022Q1 sci Recognized Revenue From Current Period
RecognizedRevenueFromCurrentPeriod
-138905000 USD
CY2021Q1 sci Recognized Revenue From Current Period
RecognizedRevenueFromCurrentPeriod
-133633000 USD
CY2022Q1 sci Changeinamountsdueforunfulfilledperformanceobligations
Changeinamountsdueforunfulfilledperformanceobligations
-36201000 USD
CY2021Q1 sci Changeinamountsdueforunfulfilledperformanceobligations
Changeinamountsdueforunfulfilledperformanceobligations
-10387000 USD
CY2022Q1 sci Deferred Revenue Change In Cancellation Allowance
DeferredRevenueChangeInCancellationAllowance
-146000 USD
CY2021Q1 sci Deferred Revenue Change In Cancellation Allowance
DeferredRevenueChangeInCancellationAllowance
113000 USD
CY2022Q1 sci Effect Of Foreign Currency And Other On Deferred Revenue
EffectOfForeignCurrencyAndOtherOnDeferredRevenue
4972000 USD
CY2021Q1 sci Effect Of Foreign Currency And Other On Deferred Revenue
EffectOfForeignCurrencyAndOtherOnDeferredRevenue
3780000 USD
CY2022Q1 sci Deferredrevenueanddeferredreceiptsheldintrust
Deferredrevenueanddeferredreceiptsheldintrust
6141979000 USD
CY2021Q1 sci Deferredrevenueanddeferredreceiptsheldintrust
Deferredrevenueanddeferredreceiptsheldintrust
5923905000 USD
CY2022Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0373
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.260
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.253
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
21
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1300000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1300000 USD
CY2022Q1 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
560625000 USD
CY2021Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
568750000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
230000000 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
155000000 USD
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
43747000 USD
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
45100000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
4026807000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
3966320000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
63863000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
65016000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3962944000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3901304000 USD
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0370
CY2022Q1 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.78
CY2021Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.79
CY2022Q1 us-gaap Interest Paid
InterestPaid
17700000 USD
CY2021Q1 us-gaap Interest Paid
InterestPaid
20100000 USD
CY2022Q1 sci Letters Of Credit Maximum Borrowing Capacity
LettersOfCreditMaximumBorrowingCapacity
33700000 USD
CY2022Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0010
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
736300000 USD
CY2022Q1 sci Bank Facility Interest Rate
BankFacilityInterestRate
0.0146 Rate
CY2021Q4 sci Bank Facility Interest Rate
BankFacilityInterestRate
0.0111 Rate
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
75000000.0 USD
CY2021Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
20000000.0 USD
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
9100000 USD
CY2022Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1000000.0 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
109000000.0 USD
CY2021Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
900000 USD
CY2022Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
44795000 USD
CY2021Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
46878000 USD
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
3835424000 USD
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
3987696000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4104234 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
256400000 USD
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
62.47
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
240300000 USD
CY2022Q1 us-gaap Revenues
Revenues
1112403000 USD
CY2021Q1 us-gaap Revenues
Revenues
1077981000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
376913000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
382443000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41704000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41669000 USD
CY2022Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-489000 USD
CY2021Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-1266000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
335698000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
342040000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
39028000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
35812000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
341000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
296798000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
306569000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1200000 USD
CY2022Q1 us-gaap Revenues
Revenues
1112403000 USD
CY2021Q1 us-gaap Revenues
Revenues
1077981000 USD
CY2022Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
95000000 USD
CY2021Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
94300000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
219513000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
228879000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161328000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169918000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163807000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172367000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2022Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
200000 USD
CY2021Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
5600000 USD
CY2022Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
701000 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
1326000 USD
CY2022Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-212000 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-60000 USD
CY2022Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-489000 USD
CY2021Q1 sci Gain Loss On Divestitures And Impairment Charges Net
GainLossOnDivestituresAndImpairmentChargesNet
-1266000 USD
CY2022Q1 sci Investment Earnings Net
InvestmentEarningsNet
45900000 USD
CY2021Q1 sci Investment Earnings Net
InvestmentEarningsNet
45000000 USD
CY2022Q1 sci Ecf Investment Earnings Net
ECFInvestmentEarningsNet
24400000 USD
CY2021Q1 sci Ecf Investment Earnings Net
ECFInvestmentEarningsNet
20800000 USD

Files In Submission

Name View Source Status
0000089089-22-000036-index-headers.html Edgar Link pending
0000089089-22-000036-index.html Edgar Link pending
0000089089-22-000036.txt Edgar Link pending
0000089089-22-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
sci-20220331.htm Edgar Link pending
sci-20220331.xsd Edgar Link pending
sci-20220331_cal.xml Edgar Link unprocessable
sci-20220331_def.xml Edgar Link unprocessable
sci-20220331_g1.jpg Edgar Link pending
sci-20220331_htm.xml Edgar Link completed
sci-20220331_lab.xml Edgar Link unprocessable
sci-20220331_pre.xml Edgar Link unprocessable
sci-331202210q.pdf Edgar Link pending
sci-3312022x10qxex101.htm Edgar Link pending
sci-3312022x10qxex311.htm Edgar Link pending
sci-3312022x10qxex312.htm Edgar Link pending
sci-3312022x10qxex321.htm Edgar Link pending
sci-3312022x10qxex322.htm Edgar Link pending
Show.js Edgar Link pending